ResearchGuide Logo

Chat support


Advanced search ?

Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.


* You can search a publisher or tap the name directly

Subject Area

* You can search a subject area or tap the name directly

Open Acess



You want to contribute ? Login first and send us the Journal infos you think is correct.
We would be pleased to have your collaboration

This journal is included in the ResearchGuide whitelist of reputable titles. Learn more here.

Open Access YES
E-ISSN 2950-0087
Area Health, Infectious Diseases, Public Health and Health Policy, Pharmacology, Toxicology and Pharmaceutics (General)

Rare. Open Research in Rare Diseases is an open-access, multidisciplinary, international journal that aims to have a clinical impact on rare disease patients. It publishes rigorously peer-reviewed articles on research that improves the well-being and quality of life of patients with rare diseases - diagnosed or undiagnosed - and their families. The journal has a broad scope, including but not limited to: -Direct clinical and psychosocial care: diagnosis, follow-up, treatment, therapeutic advances, clinical trials, quality of life -Increasing diagnostic yield and early diagnosis: implementation of new DNA techniques, provision of genetic tests and newborn screening -Pharmacology: development and regulation of orphan drugs -Application of technologies to diagnose or interpret genetic variants -Health economics and public policies: regulatory, reimbursement policies -Legal perspectives: data sharing, privacy issues -Ethics: primary prevention and family information -Patient contributions to research: late diagnosis (patient journey) -International collaborative projects, initiatives by associations and the rare disease community. The journal is open in every sense: patients are encouraged to contribute with their experiences and needs, as they are one of the pillars of medical research. Publication formats include full-length research articles, reviews, case reports, correspondence, short communications, and commentaries.


  1. It is an oppen access journal
  2. The Subject Area : Health, Infectious Diseases, Public Health and Health Policy, Pharmacology, Toxicology and Pharmaceutics (General)
Guide page

Visit the Journal "Rare" Guide

Informations To Know

Quartile Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4.
Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

H-Index is a metric that is commonly used to evaluate the productivity and impact of individual researchers, rather than journals. However, some researchers have proposed adapting the h-index to measure the impact and prestige of scientific journals.
The h-index for the journal is the highest number of articles that have received at least that number of citations.
For example, if a journal has published 100 articles, and the most highly cited article has been cited 50 times, the h-index for the journal would be 50.

How to contribute ?

  • A journal contribution refers to written content submitted by an external or internal contributor to the journal.
  • This contribution may have corrections to Journal data.
  • Contributions are often published in specific sections of the journal after approval by the admins.
  • A contribution for a newspaper must be informative, well-structured, relevant to the newspaper's audience and respects the format of the information displayed
  • When you submit a contribution to a journal, it will be sent to the admins for verification. Contributions can be submitted by professional journalists, experts in the field, academics or anyone with an interest and expertise in the subject matter.
  • The contribution requires logging in to this website. Then, you can send a contribution request by clicking the 'To Contribute' button after editing the data inline.